MPAN
MCID: MTC036
MIFTS: 27

Mitochondrial Membrane Protein-Associated Neurodegeneration (MPAN)

Categories: Eye diseases, Muscle diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Mitochondrial Membrane Protein-Associated Neurodegeneration

MalaCards integrated aliases for Mitochondrial Membrane Protein-Associated Neurodegeneration:

Name: Mitochondrial Membrane Protein-Associated Neurodegeneration 24 53 25
Neurodegeneration with Brain Iron Accumulation 4 53 25 73
Nbia4 24 53 25
Mpan 53 25
Mitochondrial Membrane Protein-Associated Neurodegeneration Due to C19orf12 Mutation 25
Neurodegeneration with Brain Iron Accumulation Due to C19orf12 Mutation 53
Neurodegeneration with Brain Iron Accumulation Type 4 53
Mitochondrial Protein-Associated Neurodegeneration 25
Nbia Due to C19orf12 Mutation 53

Classifications:



Summaries for Mitochondrial Membrane Protein-Associated Neurodegeneration

NIH Rare Diseases : 53 The following summary is from Orphanet, a European reference portal for information on rare diseases and orphan drugs.Orpha Number: 289560Disease definitionMitochondrial membrane protein-sssociated neurodegeneration (MPAN), also known as neurogeneration with brain iron accumulation (NBIA) due to C19orf12 mutations, is an autosomal recessive neurodegenerative disorder characterized by iron accumulation in specific regions of the brain, usually the basal ganglia, and associated with slowly progressive pyramidal (spasticity) and extrapyramidal (dystonia) signs, motor axonal neuropathy, optic atrophy, cognitive decline, and neuropsychiatric abnormalities.EpidemiologyMPAN is an extremely rare disease with an estimated worldwide prevalence of about 1/1,000,000. MPAN accounts for approximately 30% of cases NBIA cases, with less than 80 cases reported to date.Clinical descriptionMPAN usually manifests during childhood (mean age: 10 years) with, gait difficulty, dysarthria and bilateral optic atrophy. Early upper motor neuron signs (pyramidal signs, e.g. spasticity) are constant findings and are later followed by signs of lower motor neuron dysfunction (deep tendon reflex loss, muscular weakness and atrophy). Progressive dystonia, parkinsonism, cognitive decline, and neuropsychiatric symptoms are present in more than half of the patients. Weight loss and bowel and/or bladder dysfunction are common.EtiologyMPAN is caused by mutations in the chromosome 19 open reading frame 12 gene ( C19orf12; 19q13.11). A founder mutation (c.204_214del11 (p.Gly69ArgfsX10)) has been described in Eastern Europe. The function of C19orf12 remains uncertain, but it may be involved in mitochondrial function, lipid homeostasis and coenzyme A metabolism.Diagnostic methodsDiagnosis is based on neuroimaging that shows evidence of iron deposits mainly in the globus pallidus and substantia nigra, often with unique T2-hyperintense streaking between the hypointense internal globus pallidus and external globus pallidus. Ophthalmologic examinations and evoked visual potentials are important to identify optic atrophy. Neuropathologic examination shows axonal spheroids, Lewy bodies and hyperphosphorylated tau-containing inclusions. Mutation analysis of the C19orf12 gene confirms the diagnosis.Differential diagnosisDifferential diagnosis includes other NBIAs, more particularly fatty acid hydroxylase-associated neurodegeneration and PLA2G6-associated neurodegeneration (see these terms). Spasticity, more prominent than dystonia, optic atrophy, motor neuropathy, and a slowly progressive course with cognitive decline help to differentiate MPAN from the other NBIAs.Antenatal diagnosisPrenatal diagnosis may be available for families in which disease-causing mutations have been identified in a previous affected sib.Genetic counselingMPAN is an autosomal recessive disorder. It is more common in consanguineous families or families of the same origin (i.e. both parents from the same small town). Parents of a patient with MPAN are obligate carriers. The risk of having an affected child in further pregnancies is of 25%.Management and treatmentThere is currently no curative treatment. Management strategies focus on the medical and surgical palliation of symptoms. Follow-up by a multidisciplinary team formed by neurologists, geneticists, ophthalmologists, physiotherapists, occupational therapists, speech and language therapists, orthopedic surgeons, and neurosurgeons is essential.PrognosisThe progression of MPAN is usually slow and may lead to loss of independent ambulation due to spasticity, dystonia, and parkinsonism; limited communication due to dysarthria and cognitive decline; and severe dementia. Life expectancy is variable. Premature death may occur due to secondary complications such as aspiration pneumonia.Visit the Orphanet disease page for more resources.

MalaCards based summary : Mitochondrial Membrane Protein-Associated Neurodegeneration, also known as neurodegeneration with brain iron accumulation 4, is related to neurodegeneration with brain iron accumulation 4 and neurodegeneration with brain iron accumulation, and has symptoms including ataxia, tremor and abnormal pyramidal signs. An important gene associated with Mitochondrial Membrane Protein-Associated Neurodegeneration is C19orf12 (Chromosome 19 Open Reading Frame 12). Affiliated tissues include brain, globus pallidus and eye, and related phenotypes are dysarthria and muscle weakness

Genetics Home Reference : 25 Mitochondrial membrane protein-associated neurodegeneration (MPAN) is a disorder of the nervous system. The condition typically begins in childhood or early adulthood and worsens (progresses) over time.

GeneReviews: NBK185329

Related Diseases for Mitochondrial Membrane Protein-Associated Neurodegeneration

Diseases related to Mitochondrial Membrane Protein-Associated Neurodegeneration via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 neurodegeneration with brain iron accumulation 4 11.7
2 neurodegeneration with brain iron accumulation 10.1
3 axonal neuropathy 10.1
4 neuropathy 10.1

Symptoms & Phenotypes for Mitochondrial Membrane Protein-Associated Neurodegeneration

Human phenotypes related to Mitochondrial Membrane Protein-Associated Neurodegeneration:

32 (show all 24)
# Description HPO Frequency HPO Source Accession
1 dysarthria 32 hallmark (90%) HP:0001260
2 muscle weakness 32 hallmark (90%) HP:0001324
3 dysphagia 32 frequent (33%) HP:0002015
4 respiratory insufficiency 32 very rare (1%) HP:0002093
5 bowel incontinence 32 frequent (33%) HP:0002607
6 behavioral abnormality 32 hallmark (90%) HP:0000708
7 optic atrophy 32 frequent (33%) HP:0000648
8 babinski sign 32 hallmark (90%) HP:0003487
9 dystonia 32 frequent (33%) HP:0001332
10 rigidity 32 hallmark (90%) HP:0002063
11 mental deterioration 32 hallmark (90%) HP:0001268
12 bradykinesia 32 frequent (33%) HP:0002067
13 shuffling gait 32 occasional (7.5%) HP:0002362
14 urinary incontinence 32 frequent (33%) HP:0000020
15 frequent falls 32 frequent (33%) HP:0002359
16 parkinsonism 32 frequent (33%) HP:0001300
17 postural instability 32 hallmark (90%) HP:0002172
18 hyperactive deep tendon reflexes 32 frequent (33%) HP:0006801
19 spastic paraparesis 32 frequent (33%) HP:0002313
20 motor axonal neuropathy 32 frequent (33%) HP:0007002
21 hand tremor 32 hallmark (90%) HP:0002378
22 abnormality of the substantia nigra 32 frequent (33%) HP:0045007
23 abnormal saccadic eye movements 32 occasional (7.5%) HP:0000570
24 abnormal globus pallidus morphology 32 frequent (33%) HP:0002453

UMLS symptoms related to Mitochondrial Membrane Protein-Associated Neurodegeneration:


ataxia, tremor, abnormal pyramidal signs, abnormality of extrapyramidal motor function, oromandibular dystonia, muscle spasticity

Drugs & Therapeutics for Mitochondrial Membrane Protein-Associated Neurodegeneration

Search Clinical Trials , NIH Clinical Center for Mitochondrial Membrane Protein-Associated Neurodegeneration

Genetic Tests for Mitochondrial Membrane Protein-Associated Neurodegeneration

Anatomical Context for Mitochondrial Membrane Protein-Associated Neurodegeneration

MalaCards organs/tissues related to Mitochondrial Membrane Protein-Associated Neurodegeneration:

41
Brain, Globus Pallidus, Eye

Publications for Mitochondrial Membrane Protein-Associated Neurodegeneration

Articles related to Mitochondrial Membrane Protein-Associated Neurodegeneration:

(show all 15)
# Title Authors Year
1
Mitochondrial membrane protein-associated neurodegeneration: a case report and literature review. ( 30088953 )
2018
2
Transcranial Sonography in Mitochondrial Membrane Protein-Associated Neurodegeneration. ( 28352978 )
2017
3
Mitochondrial membrane protein-associated neurodegeneration. ( 28359667 )
2017
4
A Novel Deletion Mutation of Exon 2 of the C19orf12 Gene in an Omani Family with Mitochondrial Membrane Protein-Associated Neurodegeneration (MPAN). ( 28042406 )
2017
5
"Eye of tiger sign" mimic in an adolescent boy with mitochondrial membrane protein associated neurodegeneration (MPAN). ( 26602591 )
2016
6
Mitochondrial membrane protein-associated neurodegeneration in a Turkish patient. ( 27857812 )
2016
7
Clinical and imaging characteristics of late onset mitochondrial membrane protein-associated neurodegeneration (MPAN). ( 27801611 )
2016
8
Mitochondrial Membrane Protein-Associated Neurodegeneration Mimicking Juvenile Amyotrophic LateralA Sclerosis. ( 27671242 )
2016
9
Eye of the tiger sign in a 23year patient with mitochondrial membrane protein associated neurodegeneration. ( 25819119 )
2015
10
Mitochondrial Membrane Protein-Associated Neurodegeneration. ( 26231266 )
2015
11
Brain iron quantification by MRI in mitochondrial membrane protein-associated neurodegeneration under iron-chelating therapy. ( 25574478 )
2014
12
Rapid disease progression in adult-onset mitochondrial membrane protein-associated neurodegeneration. ( 23278385 )
2013
13
Transcranial sonography in mitochondrial membrane protein-associated neurodegeneration. ( 23871464 )
2013
14
Mitochondrial membrane protein-associated neurodegeneration (MPAN). ( 24209434 )
2013
15
Mitochondrial Membrane Protein-Associated Neurodegeneration ( 24575447 )
1993

Variations for Mitochondrial Membrane Protein-Associated Neurodegeneration

Expression for Mitochondrial Membrane Protein-Associated Neurodegeneration

Search GEO for disease gene expression data for Mitochondrial Membrane Protein-Associated Neurodegeneration.

Pathways for Mitochondrial Membrane Protein-Associated Neurodegeneration

GO Terms for Mitochondrial Membrane Protein-Associated Neurodegeneration

Sources for Mitochondrial Membrane Protein-Associated Neurodegeneration

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....